Haifaa Abdulhaq, MD

Clinical Professor of Medicine
Medicine - Fresno
+1 559 499-6500

Haifaa Abdulhaq, M.D.
Clinical Professor, UCSF

Haifaa Abdulhaq, M.D. is Clinical Professor in Hematology and Oncology, UCSF and she is the director of hematology at UCSF Fresno and the director of Hematology/Oncology fellowship program at UCSF Fresno. She is board certified in hematology and medical oncology with expertise in Malignant Hematology including Lymphoproliferative neoplasms, Myeloproliferative neoplasms, Acute Leukemia, Multiple Myeloma and interest in Stem Cell transplantation.

Dr. Abdulhaq completed her residency in internal medicine and fellowship in hematology & oncology at Western Pennsylvania Hospital and Allegheny General Hospital in Pittsburgh, Pennsylvania.

She is a member of The American Society of Hematology, the American Board of Internal Medicine, the American Society of Clinical Oncology and the American Society of Blood and Bone Marrow Transplantation. Dr. Abdulhaq is a board member of the Leukemia and Lymphoma Society, Central California Chapter and she also serves as the chair of Cancer Committee at Community Medical Centers.

Dr. Abdulhaq has special interest in medical education. She is a recipient of Henry Kaiser Award for Excellence in teaching at UCSF . She is also interested in clinical research and serves as the principal investigator on many clinical trials in malignant hematology.

Publications: 

Disparities in Genetic Profiles, Risk Stratification and Outcomes in Adults with Acute Myeloid Leukemia Comparing Patients of Hispanic and Non-Hispanic Ethnicity in Central California.

Blood

Omar Mahmood, Tanjot Saini, Daniel Park, Sundeep Bekal, Inderpreet Bal, Simran Saini, Tabark Altai, Yousef Fayed, Yueqi Yan, Haifaa Abdulhaq

Optimizing Acute Sickle Cell Care at Community Health Partners Medical Center.

Blood

Jeffrey T Means, Nicole Palmer, Jeffrey Uller, Daniel Park, Andrew Hwang, Brian Chinnock, Marsha Treadwell, Patrick Macmillan, Haifaa Abdulhaq, Wesley Viau, Nivedana Ravi, Sani Bukari

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups.

Blood

Elizabeth A. Brem, John M. Burke, Mirko Vukcevic, Pia Kloepfer, Kimberly Saverno, Haifaa Abdulhaq, Andrew M Evens, Pierluigi Porcu, Mazyar Shadman, Christopher R. Flowers

Trends in Diffuse Large B-Cell Lymphoma Mortality in the United States: A Comprehensive Review from 2000 to 2020.

Blood

Abdul Rahman Al Armashi, Anas Al Zubaidi, Omar Mahmood, Marisa Thierheimer, Akram Alkrekshi, Haifaa Abdulhaq

Trial in Progress: A Phase I/II Study of Tafasitamab Plus Lenalidomide in Patients with Relapsed CNS Lymphoma.

Blood

Michael P Randall, Andreas Rauschecker, Liam Gima-Lange, Jenai Wilmoth, Lingjing Chen, Ming Lu, Huimin Geng, Haifaa Abdulhaq, James L. Rubenstein

Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study.

European journal of haematology

Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Clinical lymphoma, myeloma & leukemia

Othman T, Quan MA, Zhang S, Gaut D, Young PA, Mahmood O, Abdulhaq H, Shieh K, Reid J, Brem EA, Hariharan N, Heyman B, Tuscano J

Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.

Clinical lymphoma, myeloma & leukemia

Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV

Disparities in Somatic Mutations and Outcomes in Primary Central Nervous System Lymphoma Comparing Patients of Hispanic and Non-Hispanic Ethnicity

Haifaa Abdulhaq, Omar Mahmood, Calvin Kuan Jung Chen, Azra Borogovac, Matthew Wieduwilt, Anand Annan, Yueqi Yan, Maher Albitar

A Phase II Trial of the Combination of Obinutuzumab, Venetoclax, and Ibrutinib in Patients with Previously Untreated Follicular Lymphoma.

Blood

Tamer Othman, Aaron S Rosenberg, John Timmerman, Benjamin Heyman, Haifaa Abdulhaq, Joseph M Tuscano

Avoiding Daratumumab Interference with Blood Typing.

Blood

Charity A Huang, Fouad Boulbol, Sundeep Bekal, Seema Policepatil, Haifaa Abdulhaq, Sani Bukari

Characteristics and Outcomes of Multiple Myeloma in Hispanic Versus Non-Hispanic Patients in Central California.

Blood

Andrew Hwang, Daniel Park, Jason Doornenbal, Inderpreet Bal, Sani Bukari, Yueqi Yan, Haifaa Abdulhaq

Disparities in Somatic Mutations and Outcomes in Primary Central Nervous System Lymphoma Comparing Patients of Hispanic and Non-Hispanic Ethnicity.

Blood

Haifaa Abdulhaq, Omar Mahmood, Calvin Kuan Jung Chen, Azra Borogovac, Matthew Wieduwilt, Anand Annan, Yueqi Yan, Maher Albitar

Impact of Timing of Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Blood

Tamer Othman, Michelle A. Quan, Shiliang Zhang, Daria Gaut, Patricia A. Young, Haifaa Abdulhaq, Kevin Shieh, Jack Reid, Elizabeth A. Brem, Benjamin Heyman, Joseph Tuscano

OCEAN (OP-103): Melflufen/Dexamethasone Compared Wth Pomalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - Subgroup Analysis in Patients Refractory to Prior Alkylators.

Blood

Fredrik Schjesvold, Heinz Ludwig, María-Victoria Mateos, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A. Bakker, Paul G. Richardson, Pieter Sonneveld

ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant.

Clinical Lymphoma Myeloma & Leukemia

Christopher R. Flowers, John M. Burke, Mirko Vukcevic, Susan Snodgrass, Kim Saverno, Mary Ann A. Lumiqued, Haifaa Abdulhaq, Elizabeth Brem, Andrew Evens, Umar Farooq, Pierluigi Porcu, Mazyar Shadman

Poster: ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant.

Clinical Lymphoma Myeloma & Leukemia

Christopher R. Flowers, John M. Burke, Mirko Vukcevic, Susan Snodgrass, Kim Saverno, Mary Ann A. Lumiqued, Haifaa Abdulhaq, Elizabeth Brem, Andrew Evens, Umar Farooq, Pierluigi Porcu, Mazyar Shadman

Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin.

Leukemia & lymphoma

Guan T, Lo M, Young R, Ai W, Boulbol F, Mouanoutoua H, Chu R, Andreadis C, Kaplan L, Abdulhaq H, Fakhri B

R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Clinical lymphoma, myeloma & leukemia

Othman T, Penaloza J, Zhang S, Daniel CE, Gaut D, Oliai C, Brem EA, Baweja A, Ly J, Reid J, Pinter-Brown L, Lee M, Abdulhaq H, Tuscano J

Clinicopathological characteristics of high-risk multiple myeloma in Hispanic versus non-Hispanic patients in central California

Journal of Clinical Oncology

Andrew Hwang, Jason Doornenbal, Daniel Park, Inderpreet Bal, Mohammed SANI Bukari, Yueqi Yan, Haifaa Abdulhaq

Clinicopathological characteristics of high-risk multiple myeloma in Hispanic versus non-Hispanic patients in central California.

Journal of Clinical Oncology

Andrew Hwang, Jason Doornenbal, Daniel Park, Inderpreet Bal, Mohammed SANI Bukari, Yueqi Yan, Haifaa Abdulhaq

Clinicopathologic Characteristic and Natural History of Patients with Non Hereditary, Non Polycythemia Vera (NH/NPV) Persistent Polycythemia.

Blood

Omar Mahmood, Hanson Mouanoutoua, Tanjot Saini, Marcel Okura, Mahboub Rahman Noori, Nadia Almasri, Haifaa Abdulhaq, Sani Bukari

Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley.

Blood

Charity A Huang, Omar Mahmood, Paul Mills, Mehdia Amini, Sundeep Bekal, Jason Doornenbal, Sani Bukari, Yabby Abejie, Haifaa Abdulhaq

Evaluation of Pulmonary Toxicities in Lymphoma Patients Receiving Brentuximab Vedotin.

Blood

Tiffany Guan, Mimi Lo, Rebecca Young, Fouad Boulbol, Hanson Mouanoutoua, Raymond Chu, Weiyun Z. Ai, Haifaa Abdulhaq, Bita Fakhri

First-Line Treatment with R-CHOP Vs Dose-Adjusted R-EPOCH for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.

Blood

Tamer Othman, Juan Penaloza, Elizabeth A Brem, Lauren C. Pinter-Brown, Abinav Baweja, Matthew Hyun Joon Lee, Jane Ly, Jack Reid, Haifaa Abdulhaq, Daria Gaut, Caspian Oliai, Erin G. Reid, Joseph M Tuscano

OCEAN (OP-103): Melflufen/Dexamethasone (Dex) Compared with Pomalidomide (Pom)/Dex in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM) - Safety and Tolerability Analyses.

Blood

Paul G. Richardson, Fredrik H. Schjesvold, Haifaa Abdulhaq, Daniel Coriu, Antonio Lazzaro, Pieter Sonneveld, Torbjörn Kullenburg, Johan Harmenberg, Marcus Thuresson, Catriona Byrne, María-Victoria Mateos

Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients.

Cancer treatment and research communications

Barakat M, Albitar M, Whitney R, Abdulhaq H

Clinicopathological Features of Double-Hit and Double-Expressor Lymphomas in Hispanics Versus Non-Hispanics in Central California

Clinicopathological Features of Double-Hit and Double-Expressor Lymphomas in Hispanics Versus Non-Hispanics in Central California

MatthewLee,TannerMortenson,MahboubNoori,DianaMoers,Mohammed Bukari, HaifaaAbdulhaq

ABCL-078: Clinicopathological Features of Double-Hit and Double-Expressor Lymphomas in Hispanics Versus Non-Hispanics in Central California.

Clinical Lymphoma Myeloma & Leukemia

Matthew Lee, Tanner Mortenson, Mahboub Noori, Diana Moers, Mohammed Bukari, Haifaa Abdulhaq

Clinicopathologic and molecular profile of Philadelphia like ALL in Hispanic population of Central Valley California.

Journal of Clinical Oncology

Hugo Akabane, Mir Ali, Haifaa Abdulhaq, Mohammed SANI Bukari

Clinicopathologic profile of extramedullary plasmacytoma in Central Valley.

Journal of Clinical Oncology

Salimah Valliani, Mohamad Barakat, Harinder Gill, Jerome Okudo, Haifaa Abdulhaq, Mohammed SANI Bukari

Leukemic infiltration in the settings of acute respiratory failure.

Oxford medical case reports

Fayed M, Evans T, Abdulhaq H

Leukemic infiltration in the settings of acute respiratory failure.

Oxford medical case reports

M Fayed, T Evans, H Abdulhaq

Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic population.

Journal of Clinical Oncology

Mohamad Barakat, Maher Albitar, Robin L. Whitney, Calvin Chen, Yu-Hung Kuo, William Silveira, Mohammed SANI Bukari, Subramanyeswara Rao Arekapudi, Karamjit Dhaliwal-Binning, Haifaa Abdulhaq

Molecular profiling of primary central nervous system lymphoma as compared to activated B-cell subtype of diffuse large B-cell lymphoma.

Journal of Clinical Oncology

Mohamad Barakat, Maher Albitar, Zijun Xu-Monette, Ken H Young, Haifaa Abdulhaq

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant.

Case reports in hematology

Rahmat LT, Nguyen A, Abdulhaq H, Prakash S, Logan AC, Mannis GN

A rare case of rosai-dorfman disease in an adult male associated with auto-immune hemolytic anemia.

Mediterranean journal of hematology and infectious diseases

Sachdeva M, Abdulhaq H

Zosteriform Rash as the First Sign of Metastatic Non-small Cell Carcinoma of the Lung (A Case Report.

Chest Journal

Mostafa Tabassomi, Haifaa Abdulhaq, Eyad Almasri, Nastran Hashemi

Viability and potency of hematopoietic progenitor cells after prolonged cryopreservation at -80°C.

Acta haematologica

Costa R, Khattab M, Gilmore GL, Sahovic EA, Miller SM, Rossetti JM, Abdulhaq H, Lister J

Activity of azacitidine in chronic myelomonocytic leukemia.

Cancer

Costa R, Abdulhaq H, Haq B, Shadduck RK, Latsko J, Zenati M, Atem FD, Rossetti JM, Sahovic EA, Lister J

Viability And Potency Of Hematopoietic Progenitor Cells After Prolonged Cryopreservation At -80 °C.

Biology of Blood and Marrow Transplantation

M. Khattab, G.L. Gilmore, E.A. Sahovic, S.M. Miller, J.M. Rossetti, H. Abdulhaq, J. Lister

Azacitidine in the Treatment of Elderly Patients with Acute Myelogenous Leukemia.

Blood

Heather L. Benjamin, James M. Rossetti, Aaron J. Lampkin, Christie Hilton, Entezam Sahovic, Haifaa Abdulhaq, Richard K. Shadduck, Namratha Vemulapalli, Amanda Hercules, John Lister

Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.

American journal of clinical oncology

Abdulhaq H, Geyer C

Activity of Azacitidine (AZA) in Chronic Myelomonocytic Leukemeia (CMML).

Blood

Haifaa Abdulhaq, Bushra Haq, James M. Rossetti, Richard K. Shadduck, Entezam Sahovic, Dijana Christianson, John Lister

Azacitidine in the Treatment of Elderly Patients with Acute Myelogenous Leukemia.

Blood

George Labban, James M. Rossetti, Richard K. Shadduck, Entezam Sahovic, Haifaa Abdulhaq, Jean Goy, Lisa Wilt, Rich Wonder, John Lister

The role of azacitidine in the treatment of myelodysplastic syndromes.

Expert opinion on investigational drugs

Abdulhaq H, Rossetti JM

Erythroid variant of chronic myelogenous leukemia.

Leukemia

Talreja N, Abdulhaq H, Shadduck RK, Rossetti J, Jalil A, Makary A, Lister J

Recent advances in myelodysplastic syndromes.

Experimental hematology

Shadduck RK, Latsko JM, Rossetti JM, Haq B, Abdulhaq H

Response to azacitidine (AZA) in patients with secondary myelodysplastic syndrome.

Journal of Clinical Oncology

H. Abdulhaq, B. Haq, J. Rossetti, J. Lister, R. Shadduck